🇺🇸 FDA
Patent

US 9994855

Compositions and methods for modulating growth hormone receptor expression

granted A61KA61K47/549A61K47/56

Quick answer

US patent 9994855 (Compositions and methods for modulating growth hormone receptor expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K47/549, A61K47/56, A61P, A61P19/00